From: A randomized controlled trial of daily weighing in pregnancy to control gestational weight gain
Characteristics | Control (n = 166) | Intervention (n = 160) | p-value |
---|---|---|---|
n (%) | n (%) | ||
Maternal clinical characteristics | |||
Gestational diabetes | 25 (15.1%) | 33 (20.6%) | 0.19 |
Hypertension or pre-eclampsia | 8 (4.8%) | 8 (5.0%) | 0.94 |
Gestation at delivery (days, n = 325, median (IQR)) | 276 (272–283) | 276 (270–283) | 0.40 |
Method of delivery | 0.80 | ||
Vaginal | 105 (63.3%) | 99 (61.9%) | |
LSCS | 61 (36.7%) | 61 (38.1%) | |
Estimated blood loss for a vaginal birth (mL, n = 202, median (IQR)) | 200 (150–338) | 225 (150–400) | 0.70 |
Estimated blood loss for a LSCS (mL, n = 122, median (IQR)) | 400 (300–600) | 500 (350–600) | 0.33 |
Percentage weight change above target rangea (mean (SD)) | 92.7 (50.8) | 86.9 (52.3) | 0.31 |
Change in weight per week during the study period (kg/wk., mean (SD)) | 0.63 (0.31) | 0.59 (0.30) | 0.22 |
Proportion above the target range | 61 (36.7%) | 50 (31.3%) | 0.30 |
Perinatal clinical characteristics | |||
Weight (g, n = 325, mean (SD)) | 3531 (489) | 3458 (480) | 0.17 |
Length (cm, n = 323, mean (SD)) | 51.4 (2.6) | 51.0 (2.4) | 0.15 |
Head circumference (cm, n = 325, median (IQR)) | 35 (34–36) | 35 (34–36) | 0.76 |
APGAR 1 min (n = 325, median (IQR)) | 9 (8–9) | 9 (8–9) | 0.95 |
APGAR 5 min (n = 322, median (IQR)) | 9 (9–9) | 9 (9–9) | 0.80 |
Admission to Special Care Nursery (n = 324) | 43 (26.1%) | 48 (30.2%) | 0.41 |
Length of stay in SCN (days, n = 90, median (IQR)) | 3 (2–4) | 2 (2–3) | 0.47 |
Fetal distress | 31 (18.7%) | 36 (22.5%) | 0.39 |